Diagnostic and prognostic significance of SLC50A1 expression in patients with primary early breast cancer

There is a lack of validated biomarkers for the diagnosis of early breast cancer (EBC). The current study aimed to determine the diagnostic and prognostic value of solute carrier family 50 member 1 (SLC50A1) in patients with EBC. Therefore, 123 patients with EBC, 30 patients with benign breast disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qunchen, Fang, Yutong, She, Chuanghong, Zheng, Rongji, Hong, Chaoqun, Chen, Chunfa, Wu, Jundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468843/
https://www.ncbi.nlm.nih.gov/pubmed/36160901
http://dx.doi.org/10.3892/etm.2022.11553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468843/
https://www.ncbi.nlm.nih.gov/pubmed/36160901
http://dx.doi.org/10.3892/etm.2022.11553

Ejemplares similares